Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2014; 20(25): 8061-8071
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8061
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8061
Figure 2 Kaplan-Meier curve indicating the survival of patients with cirrhosis (A) and patients with cirrhosis and hepatocellular carcinoma (B).
A: Kaplan-Meier curve indicating the survival of cirrhotic patients with and without sarcopenia. The 6-m probability of survival was 71% and 90%, respectively (P = 0.005, Log-Rank test); B: Kaplan-Meier curve indicating the survival of patients with cirrhosis and hepatocellular carcinoma with and without sarcopenia. The 6-mo probability of survival was 67% and 90%, respectively (P = 0.003, Log-Rank test).
- Citation: Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014; 20(25): 8061-8071
- URL: https://www.wjgnet.com/1007-9327/full/v20/i25/8061.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i25.8061